Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Phillip R. Pittman, David McClain, Xiaofei Quinn, Kevin M. Coonan, Joseph Mangiafico, Richard S. Makuch, John Morrill, Clarence J. Peters
Dive into the research topics of 'Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans'. Together they form a unique fingerprint.